PLRX Pliant Therapeutics, Inc. - Common Stock
NASDAQ · Pharmaceuticals · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 11, 2026
$1.04
· % 处于52周区间
· 高于低点
· 至高点
$1.0252周低点
$1.9552周高点
市值 (MRQ)
$64M
P/E
-0.4
EPS
$-2.43
收入
$0
PLRX 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$1.03
市值 (MRQ)
$64M
P/E
-0.4
EPS
$-2.43
收入
$0
ROE
-74.4%
52周区间
$1–$2
PLRX 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
关于 Pliant Therapeutics, Inc. - Common Stock 公司概况（来自维基百科）
行业板块Healthcare
行业Pharmaceuticals
员工49
国家US
10年表现 收入、净利润、利润率和每股收益趋势
收入$02019-12-31 → 2025-12-31
EPS$-2.432019-12-31 → 2025-12-31
自由现金流$-129M2020-12-31 → 2025-12-31
净利率·2020-12-31 → 2023-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | PLRX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E | -0.45年均值 ≈-4.5 | ≈-4.5 | · | · | |
| 市净率 (MRQ) | 0.45年均值 ≈2.1 | ≈2.1 | 3.9 | 低估 | |
| 股价/自由现金流 (TTM) | -0.95年均值 ≈-6.2 | ≈-6.2 | · | · | |
| 市现率 (TTM) | -0.95年均值 ≈-6.3 | ≈-6.3 | · | · | |
| Price / Tangible Book (市净率（有形资产）) | 0.45年均值 ≈2.1 | ≈2.1 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | PLRX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| ROA | -48.0%5年均值 ≈-43.7% | ≈-43.7% | -53.7% | 持平 | |
| ROE | -74.4%5年均值 ≈-52.5% | ≈-52.5% | -120.8% | 顶尖 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | PLRX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 9.95年均值 ≈13.7 | ≈13.7 | 4.3 | 流动性强 | |
| Quick Ratio (速动比率) | 11.75年均值 ≈13.4 | ≈13.4 | 4.1 | 流动性强 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | PLRX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | -83.7%5年均值 ≈-45.9% | ≈-45.9% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | -66.4% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | PLRX | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.05年均值 ≈0.0 | ≈0.0 | 0.0 | 弱 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$0.00 | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.86%
下次报告
十一月 04, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 5, 2026 | $-0.36 | $-0.35 | -3.2% |
| 2026年3月31日 | 五月 6, 2026 | $-0.32 | $-0.36 | 12.0% |
| 2025年12月31日 | $-0.38 | $-0.39 | 1.5% | |
| 2025年9月30日 | $-0.43 | $-0.53 | 19.5% | |
| 2025年6月30日 | $-0.71 | $-0.71 | -0.10% | |
| 2025年3月31日 | $-0.92 | $-0.74 | -24.5% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $2M | $10M | $8M | $42M | $57M | |
| R&D Expense | $109M | $169M | $128M | $97M | $78M | $66M | $47M | |
| SG&A Expense | $47M | $59M | $58M | $40M | $28M | $17M | $11M | |
| Operating Expenses | $156M | $228M | $186M | $137M | $105M | $83M | $58M | |
| Operating Income | $-156M | $-228M | $-184M | $-127M | $-98M | $-42M | $-1M | |
| Interest Expense | · | · | $1M | $791.0K | $0 | · | · | |
| Interest Income | · | · | · | · | · | $478.0K | $816.0K | |
| Other Non-op | · | · | · | · | · | $-366.0K | $-216.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-149M | $-210M | $-161M | $-123M | $-97M | $-42M | $-631.0K | |
| EPS (Basic) | $-2.43 | $-3.47 | $-2.75 | $-2.94 | $-2.71 | $-1.95 | $-4.22 | |
| EPS (Diluted) | $-2.43 | $-3.47 | $-2.75 | $-2.94 | $-2.71 | $-1.95 | $-4.22 | |
| Shares (Basic) | 61,366,887 | 60,538,639 | 58,719,083 | 42,015,908 | 35,846,421 | 21,344,236 | 1,623,358 | |
| Shares (Diluted) | 61,366,887 | 60,538,639 | 58,719,083 | 42,015,908 | 35,846,421 | 21,344,236 | 1,623,358 | |
| EBITDA | $-156M | $-228M | $-184M | $-127M | · | $-42M | · |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $45M | $71M | $63M | $34M | $52M | $51M | $86M | |
| Short-term Investments | $145M | $285M | $431M | $298M | $149M | $226M | $17M | |
| Receivables | · | · | $0 | $2M | $2M | $9M | $7M | |
| Prepaid Expense | $4M | $7M | $11M | $7M | $7M | $4M | $2M | |
| Current Assets | $196M | $362M | $506M | $340M | $209M | $291M | $112M | |
| PP&E (Net) | $3M | $6M | $4M | $4M | $5M | $4M | $4M | |
| PP&E (Gross) | $14M | $16M | $12M | $11M | $10M | $8M | $6M | |
| Accum. Depreciation | $11M | $11M | $9M | $7M | $5M | $3M | $2M | |
| Other Non-current Assets | $392.0K | $435.0K | $392.0K | $394.0K | $838.0K | $451.0K | $3M | |
| Total Assets | $225M | $397M | $512M | $351M | $221M | $296M | $119M | |
| Accounts Payable | $480.0K | $6M | $5M | $2M | $3M | $2M | $1M | |
| Accrued Liabilities | $10M | $12M | $10M | $9M | $12M | $10M | $7M | |
| Current Liabilities | $16M | $33M | $29M | $24M | $17M | $12M | $8M | |
| Capital Leases | $28M | $29M | $0 | $3M | $5M | $0 | · | |
| Other Non-current Liabilities | · | · | · | · | $0 | $866.0K | $912.0K | |
| Total Liabilities | $44M | $93M | $39M | $37M | $22M | $12M | $9M | |
| Long-term Debt | $0 | $30M | $10M | $10M | $0 | · | · | |
| Common Stock | $6.0K | $6.0K | $6.0K | $5.0K | $3.0K | $3.0K | $1.0K | |
| Retained Earnings | $-859M | $-710M | $-500M | $-338M | $-215M | $-118M | $-76M | |
| AOCI | $-15.0K | $321.0K | $345.0K | $-2M | $-201.0K | $-32.0K | $-1.0K | |
| Stockholders' Equity | $181M | $304M | $474M | $313M | $199M | $283M | $-76M | |
| Liabilities + Equity | $225M | $397M | $512M | $351M | $221M | $296M | $119M | |
| Shares Outstanding | 61,449,290 | 60,860,838 | 59,921,002 | 48,941,254 | 36,083,301 | 35,552,795 | 1,846,024 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $26M | $38M | $44M | $23M | $10M | $4M | $2M | |
| Operating Cash Flow | $-128M | $-156M | $-116M | $-95M | $-75M | $-37M | $-3M | |
| CapEx | $374.0K | $4M | $921.0K | $2M | $2M | $2M | $964.0K | |
| Investing Cash Flow | $134M | $140M | $-127M | $-150M | $74M | $-211M | $-18M | |
| Financing Cash Flow | $-32M | $23M | $274M | $227M | $3M | $213M | $46M | |
| Net Change in Cash | $-26M | $8M | $31M | $-18M | $783.0K | $-35M | $25M | |
| Taxes Paid | $0 | $0 | · | · | · | · | · | |
| Free Cash Flow | $-129M | $-159M | $-117M | $-96M | · | $-39M | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | -11654.8% | -1313.4% | · | -99.6% | · | |
| Net Margin | · | · | -10211.1% | -1273.3% | · | -99.3% | · | |
| EBITDA Margin | · | · | -11654.8% | -1313.4% | · | -99.6% | · | |
| ROA | -48.0% | -46.3% | -37.4% | -43.1% | · | -20.0% | · | |
| ROE | -74.4% | -64.7% | -33.0% | -37.9% | · | -14.2% | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.0 | 10.9 | 17.7 | 14.2 | · | 25.1 | · | |
| Quick Ratio | 11.7 | 10.7 | 17.3 | 13.9 | · | 24.7 | · | |
| Interest Coverage | · | · | -145.3 | · | · | · | · |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.2 | · | |
| Receivables Turnover | · | · | 1.6 | 4.9 | · | 5.1 | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.95 | $5.00 | $7.90 | $6.40 | · | $7.96 | · | |
| Revenue / Share | $0.00 | $0.00 | $0.03 | $0.23 | · | $1.96 | · | |
| Cash Flow / Share | $-2.09 | $-2.57 | $-1.98 | $-2.25 | · | $-1.75 | · | |
| Cash / Share | $0.74 | $1.17 | $1.06 | $0.69 | · | $1.43 | · | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | $0.00 | · | $0.00 | · | |
| Dividend Paid / Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | · | |
| EPS (TTM) | $-2.43 | $-3.47 | $-2.75 | $-2.94 | $-2.71 | $-1.95 | · |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | -83.7% | 27.9% | -81.9% | · | · | |
| Revenue CAGR 3Y | · | · | -66.4% | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $2M | $10M | $8M | $42M | · | |
| Net Income TTM | $-149M | $-210M | $-161M | $-123M | $-97M | $-42M | · | |
| Market Cap | $75M | $802M | $1.09B | $946M | · | $808M | · | |
| P/E | -0.5 | -3.8 | -6.6 | -6.6 | -5.0 | -11.7 | · | |
| P/S | · | · | 686.8 | 97.7 | · | 19.3 | · | |
| P/B | 0.4 | 2.6 | 2.3 | 3.0 | · | 2.9 | · | |
| P / Tangible Book | 0.4 | 2.6 | 2.3 | 3.0 | · | 2.9 | · | |
| P / Cash Flow | -0.6 | -5.2 | -9.3 | -10.0 | · | -21.7 | · | |
| P / FCF | -0.6 | -5.0 | -9.3 | -9.8 | · | -20.8 | · | |
| Earnings Yield | -199.2% | -26.4% | -15.2% | -15.2% | -20.1% | -8.6% | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $248.0K | $1M | $1M | $5M | |
| R&D Expense | $17M | $14M | $16M | $18M | $32M | $43M | $39M | $48M | $46M | $37M | $33M | $32M | $33M | $29M | $25M | $26M | |
| SG&A Expense | $7M | $8M | $8M | $10M | $13M | $15M | $15M | $14M | $15M | $15M | $14M | $15M | $15M | $14M | $9M | $8M | |
| Operating Expenses | $24M | $22M | $24M | $28M | $46M | $59M | $53M | $62M | $61M | $52M | $47M | $48M | $48M | $43M | $33M | $35M | |
| Operating Income | $-24M | $-22M | $-24M | $-28M | $-46M | $-59M | $-53M | $-62M | $-61M | $-52M | $-47M | $-48M | $-47M | $-42M | $-32M | $-30M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $445.0K | · | $317.0K | $319.0K | $311.0K | $301.0K | $173.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-22M | $-20M | $-24M | $-26M | $-43M | $-56M | $-50M | $-58M | $-56M | $-47M | $-41M | $-41M | $-41M | $-38M | $-31M | $-30M | |
| EPS (Basic) | $-0.36 | $-0.32 | $-0.37 | $-0.43 | $-0.71 | $-0.92 | $-0.82 | $-0.95 | $-0.92 | $-0.78 | $-0.68 | $-0.70 | $-0.70 | $-0.67 | $-0.65 | $-0.82 | |
| EPS (Diluted) | $-0.36 | $-0.32 | $-0.37 | $-0.43 | $-0.71 | $-0.92 | $-0.82 | $-0.95 | $-0.92 | $-0.78 | $-0.68 | $-0.70 | $-0.70 | $-0.67 | $-0.65 | $-0.82 | |
| Shares (Basic) | 61,919,233 | 61,803,467 | · | 61,406,475 | 61,386,183 | 61,222,676 | · | 60,730,935 | 60,382,796 | 60,180,921 | · | 59,688,451 | 59,172,869 | 56,057,603 | 46,799,058 | 36,173,135 | |
| Shares (Diluted) | 61,919,233 | 61,803,467 | · | 61,406,475 | 61,386,183 | 61,222,676 | · | 60,730,935 | 60,382,796 | 60,180,921 | · | 59,688,451 | 59,172,869 | 56,057,603 | 46,799,058 | 36,173,135 | |
| EBITDA | $-24M | $-22M | · | $-28M | $-46M | $-59M | · | $-62M | $-61M | $-52M | · | $-48M | $-47M | $-42M | $-32M | $-30M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $25M | $22M | $45M | $94M | $87M | $92M | $71M | $80M | $80M | $114M | $63M | $58M | $55M | $103M | $45M | $25M | |
| Short-term Investments | $133M | $149M | $145M | $148M | $176M | $214M | $285M | $325M | $356M | $368M | $431M | $466M | $500M | $475M | $316M | $139M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | $0 | $2M | $3M | $1M | $5M | |
| Prepaid Expense | $4M | $3M | $4M | $4M | $5M | $6M | $7M | $6M | $11M | $8M | $11M | $11M | $9M | $8M | $4M | $5M | |
| Current Assets | $163M | $175M | $196M | $246M | $267M | $311M | $362M | $410M | $448M | $490M | $506M | $534M | $566M | $588M | $366M | $174M | |
| PP&E (Net) | $2M | $3M | $3M | $4M | $5M | $5M | $6M | $6M | $5M | $6M | $4M | $4M | $4M | $4M | $5M | $5M | |
| PP&E (Gross) | $13M | $13M | $14M | $16M | $17M | $16M | $16M | $16M | $15M | $15M | $12M | $12M | $12M | $11M | $11M | $10M | |
| Accum. Depreciation | $11M | $10M | $11M | $12M | $12M | $11M | $11M | $10M | $10M | $9M | $9M | $8M | $8M | $7M | $6M | $6M | |
| Other Non-current Assets | $554.0K | $389.0K | $392.0K | $392.0K | $391.0K | $427.0K | $435.0K | $427.0K | $437.0K | $392.0K | $392.0K | $392.0K | $672.0K | $644.0K | $397.0K | $913.0K | |
| Total Assets | $190M | $203M | $225M | $277M | $300M | $345M | $397M | $446M | $484M | $522M | $512M | $540M | $575M | $598M | $377M | $185M | |
| Accounts Payable | $2M | $362.0K | $480.0K | $485.0K | $1M | $6M | $6M | $7M | $3M | $7M | $5M | $3M | $2M | $1M | $3M | $3M | |
| Accrued Liabilities | $4M | $4M | $10M | $8M | $7M | $7M | $12M | $10M | $8M | $6M | $10M | $8M | $7M | · | $20M | $17M | |
| Current Liabilities | $16M | $10M | $16M | $18M | $21M | $28M | $33M | $40M | $31M | $30M | $29M | $27M | $30M | $23M | $26M | $23M | |
| Capital Leases | $26M | $27M | $28M | $28M | $29M | $29M | $29M | $30M | $30M | $24M | $0 | $0 | $2M | $3M | $4M | $4M | |
| Total Liabilities | $43M | $37M | $44M | $76M | $80M | $88M | $93M | $100M | $91M | $84M | $39M | $37M | $42M | $36M | $40M | $37M | |
| Long-term Debt | $0 | $0 | $0 | $30M | $30M | $30M | $30M | $30M | $30M | $30M | $10M | $10M | $10M | $10M | $10M | $10M | |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $3.0K | |
| Retained Earnings | $-902M | $-879M | $-859M | $-836M | $-810M | $-766M | $-710M | $-660M | $-603M | $-547M | $-500M | $-459M | $-417M | $-376M | $-303M | $-273M | |
| AOCI | $-397.0K | $-341.0K | $-15.0K | $34.0K | $-1.0K | $159.0K | $321.0K | $848.0K | $-617.0K | $-489.0K | $345.0K | $-2M | $-2M | $-1M | $-2M | $-1M | |
| Stockholders' Equity | $147M | $165M | $181M | $200M | $220M | $257M | $304M | $346M | $393M | $437M | $474M | $503M | $533M | $562M | $337M | $148M | |
| Liabilities + Equity | $190M | $203M | $225M | $277M | $300M | $345M | $397M | $446M | $484M | $522M | $512M | $540M | $575M | $598M | $377M | $185M | |
| Shares Outstanding | 61,920,154 | 61,914,569 | 61,449,290 | 61,449,290 | 61,386,183 | 61,386,183 | 60,860,838 | 60,849,503 | 60,425,144 | 60,318,542 | 59,921,002 | 59,890,980 | 59,222,685 | 58,978,902 | 48,749,842 | 36,182,297 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $4M | $5M | $6M | $6M | $9M | $8M | $9M | $11M | $10M | $9M | $10M | $13M | $12M | $5M | $3M | |
| Operating Cash Flow | $-13M | $-19M | $-18M | $-21M | $-41M | $-49M | $-48M | $-32M | $-45M | $-30M | $-25M | $-36M | $-25M | $-30M | $-18M | $-24M | |
| CapEx | $0 | $0 | $0 | $0 | $112.0K | $262.0K | $209.0K | $896.0K | $1M | $1M | $61.0K | $94.0K | $603.0K | $163.0K | $696.0K | $254.0K | |
| Investing Cash Flow | $15M | $-4M | $2M | $28M | $35M | $69M | $39M | $31M | $11M | $60M | $32M | $38M | $-23M | $-174M | $-178M | $6M | |
| Financing Cash Flow | $0 | $74.0K | $-32M | $72.0K | $0 | $498.0K | $102.0K | $543.0K | $684.0K | $22M | $219.0K | $699.0K | $161.0K | $273M | $216M | $10M | |
| Net Change in Cash | $3M | $-23M | $-48M | $7M | $-5M | $21M | $-8M | $-770.0K | $-34M | $51M | $7M | $3M | $-48M | $69M | $20M | $-7M | |
| Free Cash Flow | · | $-19M | · | · | · | $-49M | · | · | · | $-32M | · | · | · | $-30M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | · | · | · | -19083.9% | -3160.3% | -2155.7% | -594.1% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | · | -16609.7% | -2818.9% | -2065.8% | -592.2% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | · | · | -19083.9% | -3160.3% | -2155.7% | -594.1% | |
| ROA | -9.1% | -7.3% | · | -7.3% | -11.1% | -13.0% | · | -11.7% | -10.5% | -8.4% | · | -9.0% | -10.8% | -9.4% | -10.0% | -13.4% | |
| ROE | -12.2% | -9.5% | · | -9.6% | -14.1% | -16.2% | · | -13.6% | -12.1% | -9.4% | · | -9.9% | -12.1% | -10.2% | -11.0% | -15.1% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.9 | 16.9 | · | 13.9 | 13.0 | 11.0 | · | 10.3 | 14.5 | 16.1 | · | 19.5 | 19.2 | 25.4 | 14.0 | 7.7 | |
| Quick Ratio | 9.6 | 16.5 | · | 13.7 | 12.8 | 10.8 | · | 10.1 | 14.1 | 15.9 | · | 19.1 | 18.9 | 25.1 | 13.8 | 7.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -117.7 | · | -150.4 | -148.4 | -135.4 | · | · |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.1 | 0.6 | 1.0 | 1.5 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.37 | $2.67 | · | $3.26 | $3.59 | $4.19 | · | $5.68 | $6.50 | $7.25 | · | $8.40 | $9.00 | $9.53 | $6.91 | $4.08 | |
| Revenue / Share | · | · | · | · | · | · | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.02 | $0.03 | $0.14 | |
| Cash Flow / Share | · | $-0.31 | · | · | · | $-0.80 | · | · | · | $-0.50 | · | · | · | $-0.54 | · | · | |
| Cash / Share | $0.40 | $0.36 | · | $1.53 | $1.41 | $1.50 | · | $1.31 | $1.33 | $1.89 | · | $0.96 | $0.93 | $1.74 | $0.92 | $0.69 | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | |
| Dividend Paid / Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | |
| EPS (TTM) | $-1.48 | $-1.83 | · | $-2.88 | $-3.40 | $-3.61 | · | $-3.33 | $-3.08 | $-2.86 | · | $-2.76 | $-2.71 | $-2.83 | $-2.93 | $-3.03 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $248.0K | · | $4M | $5M | $10M | $10M | $10M | |
| Net Income TTM | $-92M | $-113M | · | $-175M | $-207M | $-220M | · | $-202M | $-185M | $-171M | · | $-155M | $-144M | $-133M | $-113M | $-109M | |
| Market Cap | $71M | $78M | · | $91M | $71M | $83M | · | $682M | $650M | $899M | · | $1.04B | $1.07B | $1.57B | $1.02B | $290M | |
| P/E | -0.8 | -0.7 | · | -0.5 | -0.3 | -0.4 | · | -3.4 | -3.5 | -5.2 | · | -6.3 | -6.7 | -9.4 | -7.1 | -2.6 | |
| P/S | · | · | · | · | · | · | · | · | · | 3624.0 | · | 293.0 | 213.5 | 160.6 | 104.8 | 29.4 | |
| P/B | 0.5 | 0.5 | · | 0.5 | 0.3 | 0.3 | · | 2.0 | 1.7 | 2.1 | · | 2.1 | 2.0 | 2.8 | 3.0 | 2.0 | |
| P / Tangible Book | 0.5 | 0.5 | · | 0.5 | 0.3 | 0.3 | · | 2.0 | 1.7 | 2.1 | · | 2.1 | 2.0 | 2.8 | 3.0 | 2.0 | |
| P / Cash Flow | · | -4.1 | · | · | · | -1.7 | · | · | · | -29.7 | · | · | · | -51.8 | · | · | |
| Earnings Yield | -129.8% | -145.2% | · | -194.6% | -293.1% | -267.4% | · | -29.7% | -28.6% | -19.2% | · | -15.9% | -15.0% | -10.6% | -14.0% | -37.8% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $0 | $0 | $2M | $10M | $8M |
| 营业利润率 % | · | · | -11654.8% | -1313.4% | · |
| 净收入 | $-149M | $-210M | $-161M | $-123M | $-97M |
| 稀释后每股收益 (EPS) | $-2.43 | $-3.47 | $-2.75 | $-2.94 | $-2.71 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 12.0 | 10.9 | 17.7 | 14.2 | · |
| 速动比率 | 11.7 | 10.7 | 17.3 | 13.9 | · |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-129M | $-159M | $-117M | $-96M | · |
机构持有人 (13F) 99 家申报者 · $56.9M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
99
持有价值
$56.9M
新仓位
12
已退出持仓
12
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 12 (-2 与上一季度对比) | 12 (-1 与上一季度对比) | 18 (-8 与上一季度对比) | 27 (0 与上一季度对比) | -1.3M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | $7001038 | 6141261 | 12.30% | 股份 |
| ADAR1 Capital Management, LLC | $6281085 | 5509724 | 11.04% | 股份 |
| VANGUARD GROUP INC | $3438255 | 2818241 | 6.04% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $2782000 | 2440351 | 4.89% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $2579628 | 2262832 | 4.53% | 股份 |
| CITADEL ADVISORS LLC | $2442138 | 2142226 | 4.29% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $2336856 | 2049874 | 4.11% | 股份 |
| Monaco Asset Management SAM | $2210172 | 1938747 | 3.88% | 股份 |
| Lynx1 Capital Management LP | $2049800 | 1798070 | 3.60% | 股份 |
| BML Capital Management, LLC | $1762596 | 1546137 | 3.10% | 股份 |
| Prosight Management, LP | $1562066 | 1370233 | 2.74% | 股份 |
| TWO SIGMA ADVISERS, LP | $1519632 | 1245600 | 2.67% | 股份 |
| Peapod Lane Capital LLC | $1492275 | 1309013 | 2.62% | 股份 |
| Woodline Partners LP | $1478049 | 1296534 | 2.60% | 股份 |
| BlackRock, Inc. | $1312384 | 1151214 | 2.31% | 股份 |
| Ikarian Capital, LLC | $1140000 | 1000000 | 2.00% | 股份 |
| Eversept Partners, LP | $1016224 | 891425 | 1.79% | 股份 |
| MARSHALL WACE, LLP | $952041 | 835124 | 1.67% | 股份 |
| Redmile Group, LLC | $880224 | 772126 | 1.55% | 股份 |
| JPMORGAN CHASE & CO | $783894 | 681647 | 1.38% | 股份 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $733157 | 643120 | 1.29% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $659954 | 578577 | 1.16% | 股份 |
| UBS Group AG | $651806 | 571760 | 1.15% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $637770 | 559447 | 1.12% | 股份 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $631138 | 553630 | 1.11% | 股份 |
| Connor, Clark & Lunn Investment Management Ltd. | $611132 | 536081 | 1.07% | 股份 |
| DAFNA Capital Management LLC | $555180 | 487000 | 0.98% | 股份 |
| XTX Topco Ltd | $502562 | 440844 | 0.88% | 股份 |
| Laurion Capital Management LP | $470587 | 412796 | 0.83% | 股份 |
| TORNO CAPITAL, LLC | $400647 | 351445 | 0.70% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $389596 | 341751 | 0.68% | 股份 |
| BOOTHBAY FUND MANAGEMENT, LLC | $345420 | 303000 | 0.61% | 股份 |
| MORGAN STANLEY | $340833 | 298976 | 0.60% | 股份 |
| SEI INVESTMENTS CO | $338909 | 297291 | 0.60% | 股份 |
| Verdad Advisers, LP | $320731 | 281343 | 0.56% | 股份 |
| ArrowMark Colorado Holdings LLC | $320555 | 281189 | 0.56% | 股份 |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $313500 | 275000 | 0.55% | 股份 |
| STATE STREET CORP | $288897 | 253418 | 0.51% | 股份 |
| Stonepine Capital Management, LLC | $262813 | 230538 | 0.46% | 股份 |
| Rangeley Capital, LLC | $256500 | 225000 | 0.45% | 股份 |
| GOLDMAN SACHS GROUP INC | $237787 | 208585 | 0.42% | 股份 |
| Congress Wealth Management LLC / DE / | $231907 | 199920 | 0.41% | 股份 |
| Marquette Asset Management, LLC | $198930 | 174500 | 0.35% | 股份 |
| HighMark Wealth Management LLC | $189495 | 166224 | 0.33% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $175232 | 153712 | 0.31% | 股份 |
| JANE STREET GROUP, LLC | $148144 | 129951 | 0.26% | 股份 |
| NORTHERN TRUST CORP | $142568 | 125060 | 0.25% | 股份 |
| ALGERT GLOBAL LLC | $140678 | 123402 | 0.25% | 股份 |
| OSAIC HOLDINGS, INC. | $131013 | 114924 | 0.23% | 股份 |
| Invesco Ltd. | $119333 | 104678 | 0.21% | 股份 |
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC, KEVIN TANG, TANG CAPITAL PARTNERS, LP, TANG CAPITAL PARTNERS INTERNATIONAL, LP, TANG CAPITAL PARTNERS III, INC, TANG CAPITAL PARTNERS IV, INC, CONCENTRA BIOSCIENCES, LLC | 2025年3月10日 | 9.60% | 初始申报 | 被动投资 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 23 位内幕人士 · 9 位高管 · 14 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Bernard Coulie | President and CEO | 2026年4月17日 A | 505601 | 0 | 1 | $-114400 |
| Keith Lamont Cummings | Chief Financial Officer | 2026年4月17日 A | 297214 | 0 | 1 | $-30723 |
| Minnie Kuo | Chief Operating Officer | 2026年4月17日 A | 37806 | 0 | 1 | $-8854 |
| David Raben | Chief Medical Officer | 2026年10月1日 A | · | 0 | 0 | $0 |
| Lily Cheung | Chief Human Resource Officer | 2026年4月17日 A | 44847 | 0 | 1 | $-9644 |
| Mike Ouimette | General Counsel & Corp. Sec'y | 2025年1月23日 A | 105544 | 0 | 0 | $0 |
| Hans Hull | Chief Business Officer | 2025年1月23日 A | 251708 | 0 | 0 | $0 |
| Eric Lefebvre | Chief Medical Officer | 2025年1月23日 A | 240224 | 0 | 0 | $0 |
| Barbara Howes | Chief Human Resource Officer | 2021年1月23日 A | 24799 | 0 | 0 | $0 |
| Flavia Borellini | 董事 | 2026年7月9日 A | · | 0 | 0 | $0 |
| Robert Iannone | 董事 | 2026年7月9日 A | · | 0 | 0 | $0 |
| Steve E. Krognes | 董事 | 2026年6月11日 A | · | 0 | 0 | $0 |
| Darren S Cline | 董事 | 2026年6月11日 A | · | 0 | 0 | $0 |
| John T Curnutte | 董事 | 2026年6月11日 A | · | 0 | 0 | $0 |
| Thomas A Mccourt | 董事 | 2026年6月11日 A | · | 0 | 0 | $0 |
| Hoyoung Huh | 董事 | 2026年6月11日 A | 239619 | 0 | 0 | $0 |
| Gayle A Crowell | 董事 | 2026年6月11日 A | · | 0 | 0 | $0 |
| Katharine Knobil | 董事 | 2025年6月5日 A | · | 0 | 0 | $0 |
| Suzanne Louise Bruhn | 董事 | 2025年6月5日 A | · | 0 | 0 | $0 |
| David E I Pyott | 董事 | 2025年6月5日 A | · | 0 | 0 | $0 |
| Smital Shah | 董事 | 2024年6月13日 A | · | 0 | 0 | $0 |
| Neil Exter | 董事 | 2022年6月16日 A | 0 | 0 | 0 | $0 |
| Charles J Homcy | · | 2021年6月29日 A | · | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 5 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| IWC · iShares Trust | 0.02% | 205246 SH | 2026年9月11日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.00% | 21830 SH | 2026年10月2日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 615799 SH | 2026年8月19日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1746470 SH | 2026年8月19日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.00% | 153712 SH | 2026年8月19日 | 每日 |
PLRX 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 10 位分析师
卖出
中位数目标
$2.00
+93.2%
0 0.0%
强烈买入
0 0.0%
买入
6 60.0%
持有
2 20.0%
卖出
2 20.0%
强烈卖出
12个月价格目标
1 位分析师 · 2026-10-04平均目标 $2.00 +93.2%
最低$2.00
平均值$2.00
最高$2.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| PLRX | $75M | -0.5 | -83.7% | · | -74.4% | · |
| NTHI | · | -2.6 | -51.8% | · | · | · |
| TELO | $46M | -4.0 | · | · | -325.7% | · |
| VRCA | $143M | -4.9 | 370.2% | -50.3% | -492.8% | · |
| RFL | · | -1.6 | 44.0% | -3328.2% | -34.6% | · |
| CING | · | · | · | · | · | · |
| ELOX | · | · | · | · | 30.1% | · |
| HYPD | $31M | -0.4 | 1318.8% | -5570.6% | -115.6% | 62.7% |
| TLPH | $56M | · | · | -51035.7% | -120.8% | · |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 11, 2026 申报